STAAR SURGICAL CO (STAA): Nasdaq/NYSE listing notice — STAAR Surgical CEO Farrell to step down Jan 31; Broadwood appoints three new directors

STAAR SURGICAL CO

CEO Stephen Farrell to step down as CEO by Jan 31, 2026; will remain as consultant for 1 year at $45k/month.
Board expands from 6 to 7; Neal Bradsher and Richard LeBuhn (Broadwood, 31% owner) and Christopher Wang (Yunqi Capital, 6.5%) appointed.
Elizabeth Yeu resigns as Board Chair and director; Board seeks new Chair and CEO.
NASDAQ audit committee noncompliance due to Yeu resignation; Company using cure period.
Cooperation agreement includes standstill until June 18, 2026; mutual non-disparagement.

item 1.01 item 3.01 item 5.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

STAAR SURGICAL CO received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(4)(B)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(4)(B)

Exact text from the filing

January 14, 2026, Elizabeth Yeu, MD resigned from the Board. Among other things, NASDAQ Listing Rule 5605 requires listed issuers such as the Company to maintain an audit committee consisting of no fewer than three independent directors. Dr. Yeu had been one of three independent directors on the Company’s Audit Committee at the time of her resignation, and therefore the Company does not presently comply with such requirement. In accordance with the Listing Rules, the Company notified NASDAQ on January 14, 2026 of such noncompliance and the Company’s intention to use the cure period provided un

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

STAAR SURGICAL CO filing history →

Source: SEC EDGAR

accession 0001193125-26-013622

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.